Global Lennox-Gastaut Syndrome Treatment Market 2019-2023

Some of the key findings from our Lennox-Gastaut syndrome treatment market forecast report are summarized below

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

Global Lennox-Gastaut syndrome treatment industry overview

Corpus callosotomy is a surgical procedure used for treating refractory generalized seizures caused due to Lennox-Gastaut syndrome (LGS). However, this surgical procedure involves craniotomy with microdissection. Therefore, companies are focusing on the development of minimally invasive procedures such as MR-guided laser interstitial thermal therapy (MRg-LITT). MRg-LITT has emerged as a safe, effective, and durable alternative of traditional open corpus callosotomy. The efficacy of MRg-LITT is also being tested in advanced surgical ablation of epileptogenic foci and corpus callosotomy. This will further boost its adoption in LGS treatment. Such advancements in surgical treatments will be one of the key trends that will impact LGS market growth in the coming years.

The identification and treatment of LGS in the early stages is necessary as it may have life-threatening consequences in pediatric patients. Moreover, LGS is a rare disease which requires greater awareness among people for early diagnosis and treatment. Several governmental and non-governmental organizations such as Genetic and Rare Diseases (GARD) Information Center, National Organization of Rare Disorders (NORD), Epilepsy Society, and Genetic Alliance Australia are educating people and providing medical care and support to LGS patients. These organizations are raising awareness about the signs, symptoms, diagnosis, and treatment of LGS. This growing awareness of LGS will subsequently boost the demand for Lennox-Gastaut syndrome treatment driving market growth at a CAGR of almost 5% during the forecast period.

Top Lennox-Gastaut syndrome treatment companies covered in this market research report

The global Lennox-Gastaut syndrome treatment market is moderately fragmented. To help clients improve their market position, this report provides an analysis of the market's competitive landscape and offers information on the products offered by various companies. Moreover, this Lennox-Gastaut syndrome treatment market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of the upcoming growth opportunities.

The report offers a detailed analysis of several leading companies including:

• Eisai Co., Ltd.
• GlaxoSmithKline plc.
• H. Lundbeck A/S
• Johnson & Johnson Services, Inc.
• Supernus Pharmaceuticals, Inc

Lennox-Gastaut syndrome treatment market segmentation based on the type

• Non-surgical treatment
• Surgical treatment

The non-surgical treatment segment will account for the highest Lennox-Gastaut syndrome treatment market share because of the recent LGS drug approvals and the adoption of ketogenic diet. This report provides an accurate prediction of the contribution of all the segments to the growth of the Lennox-Gastaut syndrome treatment market size.

Lennox-Gastaut syndrome treatment market segmentation based on geographic region

• Asia
• Europe
• North America
• ROW

With a complete study of the growth opportunities for companies, it has been identified that North America will account for the highest share of the Lennox-Gastaut syndrome treatment market throughout the forecast period. The rising awareness of LGS, increasing investments in research on LGS, and strategic alliances among companies will drive LGS market growth in this region.

Key highlights of the global Lennox-Gastaut syndrome treatment market for the forecast years 2019-2023:

• CAGR of the market during the forecast period 2019-2023
• Detailed information on factors that will accelerate the growth of the Lennox-Gastaut syndrome treatment market during the next five years
• Precise estimation of the global Lennox-Gastaut syndrome treatment market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the Lennox-Gastaut syndrome treatment industry across Asia, Europe, North America, and ROW
• A thorough analysis of the market's competitive landscape and detailed information on several vendors
• Comprehensive details of factors that will challenge the growth of Lennox-Gastaut syndrome treatment companies  

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch